首页|期刊导航|浙江大学学报(医学版)|左归丸关键活性成分槲皮素可通过PI3K/Akt信号通路干预阿尔茨海默病模型细胞

左归丸关键活性成分槲皮素可通过PI3K/Akt信号通路干预阿尔茨海默病模型细胞OA

Quercetin,a key bioactive component of Zuogui Pill,protects against Alzheimer's disease by regulating the PI3K/Akt signaling pathway

中文摘要英文摘要

目的:探究左归丸关键活性成分槲皮素通过磷脂酰肌醇3激酶(PI3K)/蛋白激酶B(Akt)信号通路对阿尔茨海默病(AD)的作用及机制.方法:首先,使用TCMSP、PubChem、SwissTargetPrediction、BATMAN-TCM数据库检索左归丸活性成分并预测其潜在作用靶点,使用Uniprot数据库规范靶点信息,结合DrugBank、GeneCards、OMIM获取的AD疾病靶点,取交集得到左归丸治疗AD的潜在靶点.基于这些靶点,采用Cytoscape 3.10.1软件与STRING数据库绘制左归丸治疗AD的蛋白质-蛋白质相互作用网络,通过计算获取左归丸治疗阿尔茨海默病的关键活性成分及核心靶点.对左归丸治疗AD的潜在靶点进行基因本体功能富集分析和京都基因和基因组数据库通路富集分析,探讨左归丸治疗AD的生物学过程及信号通路.然后,使用CB-Dock2对关键活性成分槲皮素与核心靶点Akt1进行分子对接与结合能力预测.最后,以β淀粉样蛋白1-42(Aβ1-42)寡聚体诱导HT22细胞构建AD细胞模型,分为小剂量槲皮素组、中剂量槲皮素组、大剂量槲皮素组、PI3K激动剂表皮生长因子(EGF)组等进行体外实验.为验证槲皮素是否通过调控PI3K/Akt信号通路发挥抗凋亡作用,另设PI3K抑制剂(LY294002)组、PI3K抑制剂+大剂量槲皮素组、PI3K抑制剂+激动剂EGF组等进行验证.采用CCK-8检测细胞活性,JC-1、钙黄绿素AM/碘化丙啶、Hoechst方法检测细胞凋亡情况,蛋白质印迹法检测PI3K/Akt信号通路和细胞凋亡相关蛋白质表达.结果:左归丸关键活性成分槲皮素通过网络化靶向Akt1等核心蛋白,显著富集于PI3K/Akt信号通路.槲皮素与Akt1具有较好的结合能力(对接结合能为-6.6 kcal/mol).在AD模型细胞及PI3K抑制剂处理后的HT22细胞中,大剂量槲皮素能明显增加细胞存活率,提高磷酸化Akt/Akt比值和B细胞淋巴瘤2(Bcl-2)表达水平(均P<0.05),降低活化型caspase-3/caspase-3比值及Bcl-2相关X蛋白(BAX)、细胞色素C表达水平(均P<0.01),抑制细胞凋亡.结论:左归丸关键活性成分槲皮素可通过调控PI3K/Akt信号通路抑制AD模型细胞凋亡,发挥干预AD的作用.

Objective:To investigate the protective mechanism of quercetin,a key bioactive component of Chinese medicine Zuogui Pill,against Alzheimer's disease(AD)via the PI3K/Akt signaling pathway.Methods:The TCMSP,PubChem,SwissTargetPrediction,and BATMAN-TCM databases were used to retrieve the active components of Zuogui Pill and predict their potential targets.Target information was standardized using the UniProt database.AD-related target genes were obtained from DrugBank,GeneCards,and OMIM,and the intersection was taken to identify the potential targets of Zuogui Pill for AD treatment.Based on these targets,a protein-protein interaction network was constructed using Cytoscape 3.10.1 and the STRING database.The key active components and core targets of Zuogui Pill for AD treatment were identified through computational analysis.Gene Ontology functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed on the potential targets to explore the biological processes and signaling pathways involved.Subsequently,molecular docking and binding affinity prediction between the key active component quercetin and the core target Akt1 were performed using the online tool CB-Dock2.An AD cell model was established by treating mouse hippocampal neuron cells(HT22)with amyloid β-protein1-42(Aβ1-42)oligomers.The cells were divided into low-,medium-,and high-dose quercetin groups,and a PI3K agonist(EGF)group for in vitro experiments.To verify whether quercetin exerts its anti-apoptotic effects by regulating the PI3K/Akt pathway,additional groups were established:PI3K inhibitor(LY294002)group,PI3K inhibitor+high-dose quercetin group,and PI3K inhibitor+EGF group.CCK-8 assay was used to detect cell viability;JC-1,Calcein-AM/PI,and Hoechst staining were used to assess apoptosis;and Western blotting was used to detect expression of PI3K/Akt signaling pathway and apoptosis related proteins.Results:Network pharmacology demonstrated that quercetin targets core proteins such as Akt1 in a network manner and is predominantly enriched in the PI3K/Akt signaling pathway.Molecular docking showed favorable binding affinity between quercetin and Akt1(binding energy:-6.6 kcal/mol).In the Aβ1-42 oligomer-induced HT22 neuronal cell model and HT22 cells treated by PI3K inhibitor,high-dose quercetin significantly increased cell viability,elevated the p-Akt/Akt ratio and Bcl-2 expression level(all P<0.05),reduced the cleaved caspase-3/caspase-3 ratio as well as the expression levels of BAX and cytochrome C(all P<0.01),and alleviated apoptosis of HT22 cells.Conclusion:Quercetin,a key bioactive component of Chinese medicine Zuogui Pill,inhibits neuronal apoptosis by regulating the PI3K/Akt signaling pathway,thereby exerting a protective effect against AD.

李光亚;李沛泽;黄柳玲;朱静文;秦秀德;陆韵薇

广州中医药大学第四临床医学院 深圳市中医院脑病与心理病科,广东 深圳 518000广州中医药大学第四临床医学院 深圳市中医院脑病与心理病科,广东 深圳 518000广州中医药大学第四临床医学院 深圳市中医院脑病与心理病科,广东 深圳 518000广州中医药大学第四临床医学院 深圳市中医院脑病与心理病科,广东 深圳 518000广州中医药大学第四临床医学院 深圳市中医院脑病与心理病科,广东 深圳 518000广州中医药大学第四临床医学院 深圳市中医院脑病与心理病科,广东 深圳 518000

医药卫生

阿尔茨海默病左归丸槲皮素细胞凋亡网络药理学PI3K/Akt信号通路体外实验HT22细胞

Alzheimer's diseaseZuogui PillQuercetinApoptosisNetwork phar-macologyPI3K/Akt signaling pathwayIn vitro experimentHT22 cell

《浙江大学学报(医学版)》 2026 (5)

414-424,11

国家自然科学基金(82405265)广东省基础与应用基础研究基金(2023A1515110832)深圳市科技计划(JCYJ20230807094801002)深圳市中医院"3030计划"中医临床研究项目(G3030202101)This study was supported by National Natural Science Foundation of China(82405265),Guangdong Basic and Applied Basic Research Foundation(2023A1515110832),Shenzhen Science and Technology Program(JCYJ20230807094801002),and"3030 Plan"TCM Clinical Research Project of Shenzhen Traditional Chinese Medicine Hospital(G3030202101).

10.3724/zdxbyxb-2025-0661

评论